ResearcherUniversity of DebrecenActive in the last 2 years
Edit Mikó
Matched on ORCID iD 0000-0001-7584-445X; OpenAlex author ID A5069569036.
Their work
- Papers
- 4 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 4
2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: 2 papers
Papers 4
- The bacterial metabolite, lithocholic acid, has antineoplastic effects in pancreatic adenocarcinoma. Last author DOI 10.1038/s41420-024-02023-1↗
- Anticarcinogenic effects of ursodeoxycholic acid in pancreatic adenocarcinoma cell models. Last author DOI 10.3389/fcell.2024.1487685↗
- The pro- and antineoplastic effects of deoxycholic acid in pancreatic adenocarcinoma cell models. Last author DOI 10.1007/s11033-023-08453-x↗
- Oncobiosis and Microbial Metabolite Signaling in Pancreatic Adenocarcinoma. Co-author DOI 10.3390/cancers12051068↗
Closest collaborators
The 4 strongest of 4 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Szandra Schwarcz · 3 shared papers, 2023–2024
- Paper Anticarcinogenic effects of ursodeoxycholic acid in pancreatic adenocarcinoma cell models. DOI 10.3389/fcell.2024.1487685↗
- Paper The bacterial metabolite, lithocholic acid, has antineoplastic effects in pancreatic adenocarcinoma. DOI 10.1038/s41420-024-02023-1↗
- Paper The pro- and antineoplastic effects of deoxycholic acid in pancreatic adenocarcinoma cell models. DOI 10.1007/s11033-023-08453-x↗
- Patrik Kovács · 3 shared papers, 2023–2024
- Paper Anticarcinogenic effects of ursodeoxycholic acid in pancreatic adenocarcinoma cell models. DOI 10.3389/fcell.2024.1487685↗
- Paper The bacterial metabolite, lithocholic acid, has antineoplastic effects in pancreatic adenocarcinoma. DOI 10.1038/s41420-024-02023-1↗
- Paper The pro- and antineoplastic effects of deoxycholic acid in pancreatic adenocarcinoma cell models. DOI 10.1007/s11033-023-08453-x↗
- Borbála Kiss · 1 shared paper, 2020
- Péter Árkosy · 1 shared paper, 2020
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.